Aprogen's largest shareholder and related parties file large shareholding report for management influence (including capital reduction adjustment)
-
Report filed for the purpose of affecting management control.
-
Reporting party: Largest shareholder of Aprogen (31.61% stake) and special related parties: GBase, Appten, Jade New Technology Association No. 79.
-
Capital reduction effective April 15, 2026, will adjust the number of shares held.
-
Reporting party financials: Assets 160,058M, Liabilities 64,874M, Equity 95,184M (consolidated, end-2025).
KOSPI Filing Information
-
Filing: Report on Large Shareholding (General)
-
Company: Aprogen Biologics (003060)
-
Submission: Aprogen, Inc.
-
Receipt: 04-30-2026